论文部分内容阅读
目的:观察协定处方2号治疗肺心病急性加重期的临床疗效。方法:将100例肺心病急性加重期患者按1∶1随机分为两组。对照组采用西医常规方法治疗,治疗组在西医常规治疗基础上加用协定处方2号中药复方治疗,疗程均为14天。治疗结束后比较两组患者临床疗效。结果:治疗组临床控制率、总有效率优于对照组(P<0.05)。结论:协定处方2号中药复方中西医结合方案治疗肺心病急性加重期,临床疗效满意。
Objective: To observe the clinical prescription of prescription No. 2 in the treatment of acute exacerbation of pulmonary heart disease. Methods: One hundred patients with acute exacerbation of pulmonary heart disease were randomly divided into two groups. The control group was treated with routine western medicine. The treatment group was treated with Chinese herbal compound prescription on the basis of routine treatment of Western medicine, both for 14 days. After treatment, the clinical efficacy of the two groups were compared. Results: The clinical control rate and total effective rate in the treatment group were better than those in the control group (P <0.05). Conclusion: The prescription of traditional Chinese medicine on the 2nd Chinese medicine combination of traditional Chinese and Western medicine treatment of acute exacerbation of pulmonary heart disease, clinical efficacy is satisfactory.